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Abstract
Raman spectroscopy has remarkable analytical abilities to scientists who want to study 
biological samples. The use of Raman spectroscopy within biologic samples has been 
increasing in the last years because it can provide biochemical information, allows dis-
crimination between two or more sample groups, and, contrary to what happens with 
other spectroscopic techniques, water has no interference in the spectra. Biological 
samples typically do not require extensive preparation, and biochemical and structural 
information extracted from spectroscopic data can be used to characterize different 
groups. This chapter presents the general features of Raman spectroscopy and Raman 
spectroscopic tools relevant to the application in health sciences. In order to emphasize 
the potential of Raman in this research field, examples of its application in oncology, in 
bacterial identification and in dementia diagnosis are given.
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1. Introduction
Spectroscopy is a relevant tool for biomedical analysis. Significant progresses in the applica-
tion of spectroscopy in clinical field were done in the last years. Spectroscopic techniques pro-
vide information at the molecular level, and it is possible to evaluate functional groups, bond 
types and molecular conformations of the biological components of a sample, once spectral 
signals in vibrational spectra are specific to each molecule and act like a fingerprint.
A spectroscopic-based metabolomic study includes sample collection, sample analysis, statis-
tical analysis and identification of altered metabolites. The resulting data can be translated into 
defining disease biomarkers/pathways, with the generation of a disease metabolic fingerprint.
Vibrational spectroscopy has been proposed as an approach to diagnosis. Raman has a past 
research regarding its potential as a diagnostic tool of a wide range of pathologies using a 
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wide range of sample types. Although being recognized as not as specific and sensitive as other 
metabolomics techniques, several works already demonstrated the potential of Raman applied 
to health sciences for metabolic fingerprinting because it is possible with only one spectra to 
simultaneously analyze carbohydrates, amino acids, fatty acids, lipids, proteins, nucleic acids 
and polysaccharides with a minimum sample preparation. As Raman is a scattering technique 
and it is not perturbed by aqueous media, it is suitable to analyze biological samples.
For diagnostic purposes, it is expected that Raman spectra of biological samples result in 
quantitative data, so it is essential to define some categorical differentiable classes for data by 
dividing samples in healthy or disease sample classes. For these purposes, chemometric data 
processing is a valuable tool.
Due to Raman spectroscopy features, it is currently widely used in health sciences for spectral 
imaging of cells and tissues, for the in-vivo and ex-vivo diagnosis of tissues, where fiber probes 
can be used, and for biofluid analysis, contributing to a better knowledge of the disease and 
disease diagnosis at the molecular level. This chapter describes the most relevant application 
of Raman in biomedical field.
2. Raman features and sampling
Raman spectroscopy is an optical technique based on inelastic scattering of light due to the 
vibration of the molecules that can provide chemical fingerprints of several samples. In health 
sciences, Raman can be used in DNA analysis, lipids, proteins and amino acids identification, 
bacteria classification and recognition, cell responses, cancer diagnosis and prognosis, and 
dental prosthesis, among others. This wide range of application is due to Raman’s capabilities 
that go far beyond of being a noninvasive and nondestructive method that does not require 
samples preparation. Raman is compatible with aqueous solutions and is also a technique that 
produces results in a short time, requiring less than a minute to obtain a good quality spectrum, 
and no sample preparation is needed. This spectroscopic technique is sensitive to identify many 
different functional groups that produce weak signals in infrared spectroscopy (C═C; S─S; 
C─S). Besides that, it has a highly selective fingerprint that allows the discrimination of similar 
molecules and has high spatial resolution that allows single cell analysis and intracellular imaging.
The ability to use advanced optical technologies in the visible or near-infrared spectral range 
(lasers, microscopes, and optic fibers) is responsible for the growth of Raman spectroscopy 
in medical diagnostic. As molecular changes in cells, tissues or biofluids can be detected and 
quantified by Raman spectroscopy, it is possible to use this technique in the diagnosis of 
diseases and to study the effects of drugs (treatments) in biosystems.
In fact, Raman spectroscopy can offer chemical fingerprints of cells, tissues (in vivo or in-vitro), 
or biofluids. A large range of samples can be used for Raman analysis: formalin-fixed and 
fresh frozen mammalian tissue, fixed cells and biofluids.
Whether a sample is a solid, liquid, powder, slurry, or gas, no sample preparation is normally 
required, and there is no need to dissolution, grinding, glass formation, or pressing in order 
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to obtain good spectroscopic outcome. Raman spectroscopy is also a nondestructive method, 
and it is possible to evaluate the chemical composition of a sample, and the same aliquot can 
be used further to extract additional biological information by using other methodologies [1].
3. Raman spectroscopic variations
In recent past, Raman spectroscopy was known as a technique with low signals requiring 
longer acquisition times. However, recent developments were made to overcome this limita-
tion in the last years. Nonlinear optical effects and metallic nanoparticles are currently used to 
improve Raman signals, fiber-optic Raman probes were introduced and are used for real-time 
in-vivo experiments, and multimodal integration with other optical techniques increased the 
acquisition speed and spatial accuracy. These advances in the accuracy allow the application 
of Raman spectroscopy into clinical diagnosis, and time of analysis allows its clinical use.
Surface enhanced Raman spectroscopy (SERS), Tip Enhanced Raman Scattering (TERS) or 
nano-Raman and resonance effects increase significantly Raman sensitivity to study biologi-
cal samples. SERS increases Raman intensity compared to the usual and weak Raman scat-
tering. These improvement features are sufficient to allow even single molecule detection 
using Raman. SERS is useful in trace material analysis, flow cytometry and other applications 
where the traditional sensitivity/speed of a Raman measurement is insufficient [2]. Resonance 
Raman spectroscopy is a variant of Raman spectroscopy that instead of using laser excitation 
at any wavelength to measure Raman scattering of the laser light, the excitation wavelength is 
used to overlap with an electronic transition. The overlap results in an extraordinary increase 
in scattering intensities, thus detection limits and measurement times can be significantly 
decreased. It is also possible to couple Raman to an optical microscope. Raman microspectros-
copy uses visible and near-infrared excitation lasers and allows to extract molecular proper-
ties of the samples with diffraction-limited spatial resolution. The typical method to obtain 
Raman spectral images is by scanning the sample with the laser spot and then applying a 
uni- or multivariate spectral model to each Raman spectrum [3]. In order to decrease the time 
of analysis, Raman spectral imaging can be based on line-mapping (laser beam is expanded 
to form a line spot on the sample surface) [4].
TERS is a chemical imaging technique that is label-free and have enhanced-resolution. TERS 
imaging is performed with a Raman spectrometer, a scanning probe microscope (SPM) inte-
grated with an optical microspectrometer. The scanning probe microscope provides the 
means for nanoscale imaging and the optical microscope provides the resources to bring the 
light to a functionalized probe, and the spectrometer is the sensor analyzing the light out-
put providing chemical specificity. It is possible to increase the signal to obtain high-spatial 
resolution spectral images for large samples using selective-sampling Raman microspectros-
copy. In this approach, it is possible to (1) obtain information about sample spatial features by 
other optical technique [5] or (2) estimate information in real-time from the Raman spectra [6]. 
When traditional variations of Raman spectroscopy are used to study tissues, the results are 
not good due to insufficient penetration depth. The advance of spatially offset Raman spec-
troscopy (SORS) overcame this limitation enabling spectral measurements until 10–20 mm of 
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the sample and, with this modification, the application of Raman in clinical fields increases 
by collecting the scattered light away from the point of laser illumination [7]. Transmission 
Raman spectroscopy (TRS) is the term used when the collection and illumination points are 
on opposite sides of the sample, and it is quite useful to analyze opaque materials. Besides, it 
was proved to be very useful to read many millimeters of tissues [8]. To increase the resolution 
of Raman microspectroscopy, it is possible to use Coherent anti-Stokes Raman spectroscopy 
(CARS) or stimulated Raman spectroscopy (SRS), both based on nonlinear optical effects that 
upgrade the spatial resolution. Coherent Raman spectroscopy techniques are based on non-
linear effects to increase the speed and spatial resolution of Raman spectroscopy by inducing 
coherent molecular vibrations in the sample increasing resolution. CARS is used to obtain 
image from cells and tissues by exciting the CH stretching vibrations of lipids and proteins 
and SRS allows to obtain high-speed images [9, 10]. Raman spectroscopy is also adaptable 
for fiber-optic probes, making it valuable for medical diagnosis in vivo, for instance in hollow 
organs. The probe should have very reduced dimensions to permit the access to body cavities, 
and the spectra acquisition time should be short to allow accurate measurement [11].
4. Multivariate analysis applied to spectroscopic data analysis
Multivariate analysis tools are used to extract information from spectral data set and to assist 
in biomedical interpretation. Chemometric methods are diverse and offer different approaches 
to extract specific information from the data. These methods used for data interpretation and 
to extract information from complex datasets were usually univariate and therefore they were 
not suitable to describe the sample variation or composition. A range of processing methods 
can be applied to a Raman data set; usually baseline corrections should be performed as a first 
approach, prior to normalization methods and then a wide range of multivariate analysis tolls 
can be applied [12].
Multivariate methods include techniques of multivariate classification (or pattern recogni-
tion techniques) and multivariate regression. Techniques of multivariate classification can 
be divided into unsupervised and supervised learning procedures. In unsupervised pattern 
recognition techniques such as principal-component analysis (PCA) and cluster analysis (CA), 
there is no need for a priori knowledge about the training set samples (spectra). These meth-
ods are used to consider differences and similarities between spectra. By contrast, supervised 
pattern recognition techniques such as linear discriminant analysis (LDA) and artificial neural 
networks (ANNS) require some a priori knowledge, for example, undoubtedly identifying 
samples from disease and samples from healthy cases. In this way, supervised procedures 
allow a more precise classification, while unsupervised methods are useful for an exploratory 
analysis of data.
On the other hand, multivariate regression techniques (or multivariate calibration methods) 
are usually applied to analyze one or multiple molecules of a complex sample that possess 
overlapping spectroscopic signals. These techniques include principal components regression 
(PCR) and partial least squares regression (PLS) (Figure 1).
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5. Raman spectroscopy in cancer diagnosis
A preeminent application of Raman spectroscopy in health sciences is its use in cancer diag-
nosis. According to Cancer Research UK, in 2012, an estimated 14.1 million new cancer cases 
occurred worldwide, resulting in 8.2 million people died [15]. Despite the majority of new 
cancer cases was registered in less-developed countries, a significative number (more than 6 
million cases) occurs in developed regions, with access to advanced medical care and treat-
ments [16]. These data reveal the urgent need of reliable diagnostic tools to reduce cancer 
cases and cancer mortality.
The common methodologies for cancer diagnosis are based on invasive histological analysis 
and biomedical imaging, which are expensive, time-consuming and can give rise to subjective 
diagnosis [17]. Raman spectroscopy has been extensively studied in an attempt to replace or 
complement current methods and increase sensitivity and specificity of the diagnosis [18]. In 
this section, we discuss the advances in Raman spectroscopy applied to biofluids and tissue 
for diagnosis of different cancer types (Figure 2).
5.1. Skin cancers
Raman has been widely investigated to discriminate benign skin lesions from malignant 
lesions, mainly basal cell carcinoma and squamous cell carcinoma (Table 1). Despite the high 
complexity of skin tissue, studies in vivo show huge potential as a routine procedure in hos-
pitals for cancer screening [19]. In 2008, a preliminary report used 289 patients with different 
Figure 1. Most frequently applied multivariate data analysis techniques in combination with spectroscopic methods. 
MVA: Multivariate data analysis; PCR: Principal component regression; PLS: Partial least-squares regression; PCA: 
Principal-component analysis; CA: Cluster analysis; LDA: Linear discriminant analysis; PLS-DA: Partial least-squares 
discriminant analysis; SIMCA: Soft independent modeling of class analogy; ANNS: Artificial neural networks. Adapted 
from [13, 14].
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types of malignant and benign skin lesions [20]. The authors applied real-time in vivo Raman 
spectroscopy to acquire spectra of all samples and analyzed data using PLS and LDA analysis. 
Direct analysis of spectra showed distinct biomolecular signatures and ROC curves allowed 
to discriminate skin cancers from benign lesions with an area under curve greater than 0.9 
[20]. Later, the same authors published another study in vivo using a higher cohort of patients 
and 518 skin lesions (both malignant and benign conditions that are visually similar to skin 
cancer) [21]. Using the same instrumentation as before [20], the authors analyzed data using 
PC-GDA and PLS analysis, once visual inspection of spectra did not show distinctive Raman 
peaks assigned to skin cancer [21]. Although Raman peaks are almost the same between nor-
mal and cancer samples, the intensity of the signals allows the discrimination between differ-
ent types of lesions and are compatible with those obtained using histopathological methods. 
To complement and validate these results, in 2015, Zhao et al. [22] added 127 samples to 
the previous cohort, creating a consolidated group. Using real-time Raman spectroscopy and 
PC-GDA, an PLS analysis obtained the same discrimination as before, proving the ability of 
Raman spectroscopy for in vivo skin cancer detection. In 2014, other in vivo study successfully 
used Raman microspectroscopy to study 20 skin samples and detect basal cell carcinoma in 
tissue removed during surgery [21].
Besides in vivo studies, there are also some studies in vitro to assess the use of Raman spectros-
copy for skin cancer detection. In 2010, Bodanese et al. used dispersive Raman spectroscopy 
and successfully distinguished normal samples from basocellular cell carcinoma [23]. They 
found spectral differences in the region between 800 and 1000 cm−1 and between 1200 and 
Figure 2. Main application areas of Raman spectroscopy in health science.
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Cancer type Study 
type
Statistical 
analysis
Sensitivity and 
specificity (%)
Spectral differences (cancer vs. 
normal)
Refs.
Skin In vivo PC-GDA, PLS 95, 54 NA [22]
Skin Ex vivo LDA, MLR 100, 92 NA [44]
Skin Ex vivo PCA 99.1, 93.3 Proteins, lipids and melanin [24]
Skin In vitro GDA ~90, ~90 Phenylalanine, tryptophan and 
DNA bases
[25]
Skin In vivo PC-GDA, PLS 90, 64 NA [21]
Skin In vitro PCA 89, 93 Lipids and proteins [23]
Skin In vivo PLS, LDA 91, 75 NA [20]
Nasopharyngeal In vivo PLS 91, 95 NA [33]
Oral Ex vivo PCA, LDA 80.7, 84.1 Nucleic acids, proteins, lipids [28]
Laryngeal In vivo PLS-DA, LOPCV 93.3, 90.1 Nucleic acids, proteins, lipids [32]
Esophageal In vivo PLS-DA, LOPCV 97, 97.4 Lipids, proteins [31]
Esophageal Ex vivo PCA 90.5, 95 NA [45]
Esophageal Ex vivo PCA, LDA 93, 95 NA [30]
Esophageal Ex vivo PCA, LDA 71–81, 81–98 NA [29]
Nasopharyngeal Ex vivo PCA, LDA 90.7, 100 Nucleic acids, collagen, 
phospholipids, phenylalanine
[27]
Gastric intestinal 
pre-cancer
In vivo PCA, LDA, 
LOPCV
89.3, 92.2 Collagen, lipids, phenylalanine, 
proteins
[36]
Gastric Ex vivo PCA-DA 90, 90.9 NA [46]
Gastric Ex vivo PCA, LDA 100, 94.1 RNA bases, ribose [35]
Gastric Ex vivo PCA, LDA 100, 97 Tyrosine, adenine, coenzyme A [34]
Breast Ex vivo Direct analysis NA Carotenoids, lipids, 
carbohydrates, proteins
[40]
Breast Ex vivo PLS-DA, LOPCV 74.2, 86.4 Collagen, amino acids [39]
Breast Ex vivo LDA, MNLR 95.6, 96.2 Nucleic acids, collagen, lipids [38]
Leukemia Ex vivo PCA, LDA 100, 100 Lipids, phospholipids, amino 
acids, carotenes
[43]
Colorectal Ex vivo PCA, LDA 97.4, 100 Nucleic acids, saccharides, 
proteins
[42]
Bladder In vitro PCA 98, 95 NA [41]
GDA: General discriminant analysis; LDA: Linear discriminant analysis; LOPCV: Leave-one patient-out cross validation; 
MLR: Multinomial logistic regression; MNLR: Multinomial logistic regression; NA: Not available; PCA: Principal 
component analysis; PC-GDA Principal component with generalized discriminant analysis; PLS: Partial least square; 
PLS-DA: Partial least square discriminant analysis.
Table 1. Raman spectroscopy in cancer diagnosis.
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1300 cm−1, assigned to proteins and lipids, using PCA multivariate analysis, with high sen-
sitivity and specificity [23]. Later, in 2012, the same author reported new results corroborat-
ing the previous study [24]. Using a Raman spectrometer attached to a fiber optic and PCA 
analysis, they analyzed 145 different samples of basocellular cell carcinoma, melanoma and 
without malignant lesions and were able to discriminate cancer and normal samples with sen-
sitivity and specificity values over 90% [24]. In the same year, a different study was performed 
by Wang H et al. using HaCaT cells, melanocytes and their malignant derivatives [25]. They 
tested the ability of micro-Raman spectroscopy to separate different cell lines and found 
significant spectral differences between HaCaT cells and squamous cell carcinoma, melano-
cytes and melanoma cells as well as between all normal cells versus all tumor cells [25] (Table 1). 
The results of these in vitro studies are of extreme importance and can help the interpretation 
spectra of in vivo samples for cancer skin diagnosis.
5.2. Oral cavity, nasopharyngeal and laryngeal cancers
In what concerns diagnostic of oral cancers, Raman spectroscopy has been widely used in bio-
fluids like blood, urine and saliva and using fiber optic probes for in vivo diagnosis (Table 1). 
The advantage of using biofluids instead of tissue is that they can be collected using noninva-
sive and painless methods [26].
In 2010, Feng et al. described for the first time the use of a surface-enhanced Raman spectros-
copy (SERS) method for plasma analysis for nasopharyngeal cancer detection using silver 
nanoparticles [27]. This type of spectroscopy produces strong signals and has a low associated 
cost. Besides, it is suitable for use with intact tissue, biofluids and during endoscopies [26]. A 
total of 76 samples were used in that study and using PCA and LDA multivariate analysis, 
the authors found a distinct biological signature between control and cancer samples mainly 
due to an increase in nucleic acids, collagen, phospholipids and phenylalanine and also a 
decrease in amino acids and saccharide in cancer samples compared to control samples [27]. 
These results gave new insights about the use of surface-enhanced Raman spectroscopy for 
noninvasive diagnostic methods. SERS using gold nanoparticles was also applied to blood 
serum to diagnose oral squamous cell carcinoma [28]. Analysis of 370 Raman spectra using 
PCA and LDA multivariate analysis allowed to discriminate serum samples of patients with 
and without neoplasia with high sensitivity and specificity [28].
The use of Raman spectroscopy in oral cancer diagnosis relies mainly on fiber optic probes, 
and data published so far present promising results. In 2010, a study showed the applicabil-
ity of fiber optic Raman probed spectroscopy to target biopsies at endoscopy [29]. This type 
of approaches can be useful to avoid excision of normal tissue for biopsy. In this way, there 
is a reduction of the burden in histopathology departments and in the number of invasive 
procedures for the patient. Later, in 2012, Almond et al. also tested a fiber optic Raman probe 
to discriminate between benign, metaplastic and neoplastic esophageal ex vivo tissue [30]. 
Results showed high sensitivity and specificity, so it is suitable to think in this approach as 
a new technique for clinical diagnosis although in vivo clinical trials are needed to confirm 
the accuracy of this probe. In 2015, fiber optic Raman spectroscopy was successfully applied 
in 48 patients during endoscopy [31]. The authors were able to simultaneously acquire both 
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fingerprint and high wavenumber Raman spectra to extract the maximum biological informa-
tion and obtained sensitivity and specificity values about 97% for the diagnosis of esopha-
geal squamous cell carcinoma [31]. Similar results were obtained with a probe designed to 
diagnose laryngeal cancer [32]. Analysis of 2124 Raman spectra of 60 patients during endos-
copy showed sensitivity and specificity above 90% for the identification of laryngeal cancer 
when combined fingerprint and high-wavenumber spectra [32]. Recently, Ming et al. [33] 
performed a pilot study in 79 patients with and without nasopharyngeal cancer and in post-
irradiated patients. They detect a specific signature for each one of the three cohorts, which 
may indicate that Raman could not only be used for diagnostic purposes but also for surveil-
lance in post-treated patients. Furthermore, the authors used a probe with only 1.8 mm, which 
is the smallest probe used in Raman diagnostics and is more suitable to be used in clinical 
endoscopies [33].
5.3. Gastric cancers
Diagnosis of gastric cancer using Raman technologies relies either on the use of fiber optic 
probes or on SERS (Table 1). In fact, SERS was applied to plasma samples to detect gastric 
cancer in a noninvasive way [34], similar to what was done to diagnose nasopharyngeal can-
cer [27]. The authors use two cohorts, with a total of 65 samples (32 patients with confirmed 
gastric cancer and 33 control patients). Using PCA and LDA multivariate analysis, it was 
observed discrimination between cancer and normal samples with sensitivity and specificity 
of 100 and 97%, respectively. In 2012, the same methodology was applied to discriminate gas-
tric cancer from normal controls based on serum RNAs, also achieving high sensitivity and 
specificity (100 and 94.1%, respectively) [35]. SERS seems to be a useful technique to apply 
in routine clinical diagnosis coupled, for instance, with endoscopy. Fiber optic probes can 
be used for in vivo identification of gastric metaplasia. Lin et al. [36] coupled fingerprinting 
and high-wavenumber Raman spectroscopy with a fiber optic Raman probe and were able 
to detect, in real-time, pre-cancerous gastric lesions. They acquired 4520 spectra in real time, 
during gastroscopy, and by using PCA and LDA analysis, they were able to identify precan-
cerous lesions with high sensitivity and specificity [36]. This can improve early diagnosis of 
neoplasia and significantly improve the efficacy of treatments.
5.4. Breast cancers
Breast cancer is the second most prevalent cancer in the world and, it is the most common 
cancer in women, causing more than 500,000 deaths every year [37]. According to these sta-
tistics, it is not surprising that Raman spectroscopy has been used as a diagnostic tool for this 
disease. Kong et al. used Raman microspectrometry to detect ductal carcinoma in tissue 
excised during breast-conserving surgery [38]. They developed a model that allowed to dis-
criminate normal and cancerous tissue in approximately 17 min, with sensitivity and specific-
ity above 95% [38]. A different approach was used by Feng et al. in 2015 [39]. Similar to what 
this group did for other types of cancer (see Table 1 for detailed information), they applied 
SERS to saliva proteins of 97 patients and were able to discriminate between control, benign 
tumors and malignant tumors with sensitivities and specificities between 72.7–75.8% and 81.2–
93.4%, respectively, using PLS-DA analysis [39]. These results give good perspectives for new 
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noninvasive diagnostic tools. Depciuch et al. acquired Raman spectra of breast biopsies and 
did direct spectral analysis without performing multivariate analysis [40]. They reported 
differences in spectral regions assigned to the principal biomolecules: lipids, sugars and 
proteins between normal and cancerous samples [40]. All these reports give new light in 
understanding the molecular mechanisms involved in breast cancer.
5.5. Other cancers
Besides skin, oral, gastric and breast cancers, Raman spectroscopy techniques are also applied 
to diagnose other types of neoplasia (Table 1), mainly in vitro. For instance, in 2011, there was 
a study that used modulated Raman spectroscopy to detect the presence of human urothelial 
cells and bladder cancer cells after cell lines were incubated with urine [41]. The results achieved 
high sensitivity and specificity and, in the future, this approach may be applied in routine urine 
exams to detect bladder cancer or to monitor patients under treatment for bladder cancer.
Blood samples are widely used in the context of diagnosis. In the case of colorectal cancer, Lin 
et al. used gold nanoparticle-based SERS in blood serum samples of 83 patients to differentiate 
Raman spectra of healthy and disease samples [42]. This approach allowed to achieve sen-
sitivity and specificity of 97.4 and 100%, respectively. Besides, the authors detected spectral 
differences between normal and cancer samples, mainly an increase in the relative amount 
of nucleic acids and a decrease in the amount of proteins in colorectal cancer patients, com-
pared to control healthy subjects [42]. Serum blood samples can also be used to monitor the 
efficacy of treatments. In the specific case of leukemia, Gonzalez et al. used standard Raman 
spectroscopy and multivariate analysis to distinguish normal samples from leukemia sam-
ples with 100% of both sensitivity and specificity [43]. The authors detect some molecular 
changes between both groups of samples, mainly in the regions of lipids, phospholipids and 
β-carotene. Therefore, this Raman-PCA technique can be easily applied as a noninvasive tool 
to diagnosis and progression evaluation of leukemia.
In the last decade, there was an increase in the use of Raman spectroscopy in the field of 
cancer diagnostic and monitoring. As it was possible to see in this section, the improvement in 
the algorithms to process Raman signals as well as the development of new SERS techniques 
and fiber optic probes allowed to produce results with high sensitivity and specificity and 
to apply Raman-based approaches in in vivo, ex vivo and in vitro clinical diagnosis of several 
cancer types in different biological samples.
6. Raman spectroscopy for bacterial identification
Correct and in-time identification of microorganisms is crucial in clinical diagnosis. Nowadays, 
despite the advances of technology and methodologies of bacterial identification, most of the 
hospitals use bacterial culture as a standard method [47, 48]. However, these approaches are 
time-consuming, and sometimes it requires more than a day until the results are available. 
This can have serious implications to patients, mainly to those with severe infections. In this 
way, there are several investigations that evaluate the potential of Raman-based approaches 
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to bacterial identification and typing and producing fast and accurate results. Raman spectra 
of bacteria are like a fingerprint, since it represents the molecular composition and it is spe-
cific for each sample. The following studies are examples of the use of Raman in the field of 
clinical microbiology.
In 2009, Willemse et al. used Raman spectroscopy to type methicillin-resistant and methicillin-
sensible Staphylococcus aureus and compare it with traditional DNA typing methods, which 
are time- and labor-consuming [49]. After spectra collection and cluster analysis, results 
showed that Raman spectroscopy has reproducibility and discrimination ability, and all 
Raman clusters were in accordance with epidemiologic data of the isolates [49]. Similar results 
were obtained by the same group using Escherichia coli and Klebsiella pneumoniae isolates [50]. 
Using SpectraCell analyzer (River Diagnostics), they obtained high reproducible spectra and 
a discriminatory power similar to traditional DNA typing methods [50]. However, Raman 
spectroscopy was not able to detect ESBL-producing E. coli transmission events even when 
coupled to High-throughput MultiLocus Sequence Typing [51]. SERS is also used in the field 
of microbiology to identify pathogens. For instance, malaria parasite can be detected using a 
SERS nanoplatform [52]. Besides, it is also possible to discriminate wild-type malaria DNA 
from mutant malaria DNA using this technique [52]. SERS was also used in milk samples to 
identify Salmonella enterica serotype Enteritidis [53]. In this study, SERS was used with Au 
nanoprobes, and the results were almost 100x more sensitive than those obtained by PCR [53].
In clinical microbiology, it would be of particular interest to apply bacterial identification 
approaches directly to biological samples. One of the possible drawbacks of using spectros-
copy in this field is that biological fluids can have complex matrixes that may mask the spe-
cific spectral signature of a given pathogen. To verify the applicability of Raman to bacterial 
identification in biofluids, Harz et al. used micro-Raman to directly analyze cerebrospinal 
fluid (CFS) of patients with bacterial meningitis [54]. Since lethality of the disease depends 
on the pathogen involved, time is crucial and it is necessary to properly identify the bacteria 
and initiate the adequate antibiotic therapy in a short period of time. In this study, the authors 
showed that CFS did not affect Raman spectra of bacteria, and it was possible to identify it 
with accuracy [54]. This corroborates the idea that Raman can be used as a diagnostic assay. 
In hospitals, it is important not only to identify the pathogen but also to understand the anti-
microbial susceptibility profile of the microorganism in order to choose the right antibiotic 
to mitigate and treat the infection. Raman spectroscopy has been recently successfully used 
with this purpose [55]. The authors were able to discriminate Raman spectra of 67 antibiotic-
susceptible strains isolated from positive blood cultures in the presence of different concen-
trations of antibiotic in only 5 h [55]. Further development of this technology could produce 
results with robustness similar to current methods used in hospitals, and therefore in the 
future, it can be applied to clinical diagnosis.
Raman-based approaches can also be used in the field of virology. It is possible to identify 
rotavirus with an accuracy above 96% using SERS fingerprinting, and the detection of the 
virus was possible even using a complex cellular matrix, although the results were not as 
sensitive as those obtained with purified samples [56]. A similar procedure was used to detect 
respiratory syncytial virus [57]. In this study, the authors applied SERS enzyme-catalyzed 
immunoassay of respiratory syncytial virus in cell lysates, and the results showed a linear 
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correlation between the intensity of spectra and the amount of virus with a detection limit 
lower than traditional methods [57].
The studies discussed in this section suggest that Raman-based approaches are a good alter-
native for real-time clinical usage, since they are easy to use, fast (it is possible to have results 
within 45 min after positive culture), reliable and can be easily applied to a wide variety of 
microorganisms, since specific dyes or labels are no need.
7. Raman spectroscopy for the diagnosis of dementia
Alzheimer’s disease is the most prevalent type of neurodegenerative dementia in the elderly 
population worldwide. The key for efficiently and accurately diagnosing dementia occurs 
during the early stages. Scientists struggle to find a blood-based method to perform an accu-
rate diagnosis of this type of dementia, which affects 35.6 million people worldwide [58].
In this context, Raman microspectroscopy was already used to analyze serum of Alzheimer’s 
disease patients, patients with other dementias and healthy controls. Data were analyzed with 
multivariate statistics for the differential identification of Alzheimer’s disease patients. The study 
was a proof of concept; however, it proves that Raman microspectroscopy and artificial neural 
network classification were able to differentiate patients with more than 95% sensitivity and 
specificity, demonstrating that Raman has potential to become a blood-based tests that may help 
clinical assessments for effective and accurate differential diagnosis of Alzheimer’s disease [59].
8. Conclusions and outlook
In the last years, there was a significant improvement in instrumentation of Raman spectros-
copy, leading to an enhancement of sensitivity and accuracy of this approach. In this way, 
Raman has been broadly used in the context of medical investigation, mainly in the oncologic 
field. Coupled to adequate chemometric analysis tools, Raman spectroscopy, mainly SERS, 
was already applied to successfully diagnose several types of cancer, infections and prelimi-
nary results are also promising in the context of Alzheimer’s disease. It is expected that in the 
next years, Raman spectroscopy can be routinely used in hospitals to in vivo diagnose and 
surveillance of several diseases, producing fast and accurate results, decreasing waiting times 
and, in this way, improving efficacy of treatments.
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